Sahajanand Medical Technologies
The medical devices company is looking to raise ₹1,500 crore via IPO, which comprises fresh issue of ₹410.33 crore and offer for sale of ₹1,089.67 crore.
The medical devices company researches, designs, develops, manufactures and markets vascular devices globally across 69 countries. It operates three research and development facilities, located in Surat, India, Galway, Ireland and Nonthaburi, Thailand.
The company intends to utilise the net proceeds from the issue towards paying off debt of ₹255 crore and rest for funding working capital requirement of its indirect foreign subsidiaries.